Evaluation of NuvastaticTM in Reducing Cancer-Related Fatigue in Colon Cancer Patients Undergoing First-Line Chemotherapy

NCT07669519 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

Fatigue
Colon Cancer

Interventions

DRUG: Nuvastatic™
DRUG: Placebo

Sponsor

Natureceuticals Sdn Bhd